Delay HCV antivirals after liver transplant, study says

07/14/2010 | Medscape (free registration)

Researchers said hepatitis C patients who have had liver transplants should not start antiviral therapy for one year after surgery unless there is a resurgence of the HCV infection. The study found prophylactic antivirals had no effect on patient or graft survival and were poorly tolerated.

View Full Article in:

Medscape (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director Medical Affairs
Edwards Lifesciences
Irvine, CA
Senior Scientist - Cell Engineering Group
Pfizer
San Francisco, CA
Medical Director - Physician
Willamette Valley Community Health
Salem, OR
Area Reimbursement Manager (CT, MA, MD, ME, NH, NJ, NY, PA, VT)
SI-BONE, INC
Multiple Locations, SL_Multiple Locations
Medical Director - Physician
Willamette Valley Community Health
Salem, OR